Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention

NCT03817125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Placebo for antibiotic
DRUG: Vancomycin pretreatment
DRUG: Nivolumab
DRUG: Matching Placebo for SER-401
DRUG: SER-401

Sponsor

Parker Institute for Cancer Immunotherapy

Collaborators

[object Object]